focus -WSS

focus

author：fashion 2025-09-27 21:55:39 - browse：87

novavax photo illo — JUSTIN TALLIS/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, all. Damian here with an update on the plight of the other Covid-19 vaccine company, Wall Street’s latest GLP-1 trade, and the quest for a universal antivenom.

The need-to-know this morning

Ocular Therapeutics announced a shakeup of its senior management team and a $325 million private placement.
Amylyx Therapeutics said results from a closely followed Phase 3 study of its treatment for ALS could come before the start of the second quarter — earlier than previously expected.
Moderna earnings are here.

Novavax’s money is going in the wrong direction

The good news for Novavax is that it’s no longer facing a $700 million dispute with a global charity organization. The bad news is that settling that dispute will force the struggling company to pay out $400 million over the next five years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

US jobless claims fall again as labor market continues to flash strength

Wisconsin governor employs partial veto to fund schools for 4 centuries

US jobless claims fall again as labor market continues to flash strength

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

Biden targets hefty hospital 'facility fees' that often surprise patients

leisure time

focus

The need-to-know this morning

Novavax’s money is going in the wrong direction

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

Hepatitis C has a cure — but many Americans still lack access to it

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Jerome Adams on the need for new antivirals for Covid

Mystery swirls around US soldier who entered North Korea days ago, officials say

State Dept. review finds Biden bears some blame for Afghanistan failures

Teachers share how revamped forgiveness program helped with their student loans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Swim instructor mom warns parents not to buy blue swimsuits for kids

hotspot

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Create a giant ice tray with this foil pan hack to keep food cold this summer

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

The stock market has soared this year, but will it last? Experts weigh in

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Home health providers sue Medicare over payment cuts

hotspot

explore

leisure time

leisure time